Predictive Oncology Inc (POAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 67 | 5 | 221 | 677 | 490 |
| Cost of Goods | 14 | 22 | 231 | 98 | 160 |
| Gross Profit | 53 | -18 | -10 | 579 | 330 |
| Operating Expenses | 2,532 | 3,587 | 2,176 | 3,416 | 4,449 |
| Operating Income | -2,465 | -3,582 | -1,955 | -2,739 | -3,959 |
| Other Income | 8 | 18 | 31 | -9 | 36 |
| Pre-tax Income | -2,457 | -3,564 | -1,924 | -2,748 | -3,923 |
| Net Income Continuous | -2,457 | -3,564 | -1,924 | -2,748 | -3,923 |
| Net Income Discontinuous | -725 | -655 | -1,551 | -415 | N/A |
| Net Income | $-3,181 | $-4,219 | $-3,475 | $-3,164 | $-3,923 |
| EPS Basic Total Ops | -10.19 | -15.59 | -12.89 | -11.69 | -14.69 |
| EPS Basic Continuous Ops | -7.95 | -13.19 | -6.99 | -10.19 | -14.72 |
| EPS Basic Discontinuous Ops | -2.25 | -2.40 | -5.85 | -1.50 | N/A |
| EPS Diluted Total Ops | -10.19 | -15.59 | -12.89 | -11.69 | -14.69 |
| EPS Diluted Continuous Ops | -7.95 | -13.19 | -6.99 | -10.19 | -14.72 |
| EPS Diluted Discontinuous Ops | -2.25 | -2.40 | -5.85 | -1.50 | N/A |
| EPS Diluted Before Non-Recurring Items | -10.20 | -15.59 | -12.74 | N/A | N/A |
| EBITDA(a) | $-2,309 | $-3,430 | $-1,437 | $-2,950 | $-3,779 |